Format

Send to

Choose Destination
JACC Cardiovasc Imaging. 2018 Aug;11(8):1150-1172. doi: 10.1016/j.jcmg.2018.06.004.

Cardiovascular Magnetic Resonance in the Oncology Patient.

Author information

1
Department of Internal Medicine, Section on Cardiovascular Medicine at the Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: jennifer.jordan@wakehealth.edu.
2
Department of Internal Medicine, Section on Cardiovascular Medicine at the Wake Forest School of Medicine, Winston-Salem, North Carolina.

Abstract

Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic resonance may be used to assess cardiac anatomy, structure, and function and to characterize myocardial tissue. This combination of features facilitates the diagnosis and management of disease processes in patients with or those who have survived cancer. This report outlines and describes prior research involving cardiovascular magnetic resonance for assessing cardiovascular disease in patients with or previously having received treatment for cancer.

KEYWORDS:

cardio-oncology; cardiovascular magnetic resonance; tissue characterization

PMID:
30092971
PMCID:
PMC6242266
DOI:
10.1016/j.jcmg.2018.06.004
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center